The-174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian poppulation

被引:26
作者
Pola, R [1 ]
Flex, A [1 ]
Gaetani, E [1 ]
Pola, P [1 ]
Bernabei, R [1 ]
机构
[1] Univ Sacred Heart, A Gemelli Hosp, Ist Patol Speciale Med, Sch Med,Lab Vasc Biol & Genet, I-00168 Rome, Italy
关键词
IL-6; gene polymorphism; inflammatory cytokines; essential hypertension;
D O I
10.1038/sj.jhh.1001462
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Several studies have proposed a relationship between blood pressure and inflammation. Interleukin-6 (IL-6) is a multifunctional cytokine involved in inflammation and tissue injury and potentially influencing blood pressure. Recently, a common polymorphism of the IL-6 gene, associated with differences in the transcription rate of the protein, has been described. The aim of this study was to investigate a possible association between genetic variations of the -174GC polymorphism of the IL-6 gene promoter and hypertension in humans. IL-6 gene promoter polymorphism was evaluated by polymerase chain reaction followed by restriction enzyme analysis in 210 elderly Italian patients affected by essential hypertension (EH) and 177 age- and sex-matched controls. The distribution of IL-6 genotypes was 85 GG, 88 GC, 37 CC in the hypertensive patients and 65 GG, 73 GC, 39 CC in the control subjects. In this elderly cohort, no statistically significant association was found between the two groups (P = 0.45 for GG homozygous, P = 0.89 for GC heterozygous and P = 0.27 for CC homozygous). In conclusion the -174 GC polymorphism of the IL-6 gene promoter is not a marker for EH in this sample of elderly Italians.
引用
收藏
页码:637 / 640
页数:4
相关论文
共 34 条
[1]   Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population [J].
Bagli, M ;
Papassotiropoulos, A ;
Knapp, M ;
Jessen, F ;
Rao, ML ;
Maier, W ;
Heun, R .
NEUROSCIENCE LETTERS, 2000, 283 (02) :109-112
[2]   Elevated levels of interleukin-6 in unstable angina [J].
Biasucci, LM ;
Vitelli, A ;
Liuzzo, G ;
Altamura, S ;
Caligiuri, G ;
Monaco, C ;
Rebuzzi, AG ;
Ciliberto, G ;
Maseri, A .
CIRCULATION, 1996, 94 (05) :874-877
[3]  
BOWCOCK A M, 1988, Genomics, V3, P8, DOI 10.1016/0888-7543(88)90152-8
[4]   ELEVATION OF PLASMA IMMUNOGLOBULIN-A IN THE SPONTANEOUSLY HYPERTENSIVE RAT [J].
CHEN, CM ;
SCHACHTER, D .
HYPERTENSION, 1993, 21 (05) :731-738
[5]   THE HUMAN BETA-FIBRINOGEN PROMOTER CONTAINS A HEPATOCYTE NUCLEAR FACTOR 1-DEPENDENT INTERLEUKIN-6-RESPONSIVE ELEMENT [J].
DALMON, J ;
LAURENT, M ;
COURTOIS, G .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (02) :1183-1193
[6]  
DZIELAK DJ, 1992, HYPERTENSION S1, V19, P36
[7]   Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects [J].
Fernández-Real, JM ;
Broch, M ;
Vendrell, J ;
Richart, C ;
Ricart, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1334-1339
[8]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376
[9]   Do immune system changes have a role in hypertension? [J].
Fu, MLX .
JOURNAL OF HYPERTENSION, 1995, 13 (11) :1259-1265
[10]  
GREENWEL P, 1995, LAB INVEST, V72, P83